1. Home
  2. LICN vs ESLA Comparison

LICN vs ESLA Comparison

Compare LICN & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$3.12

Market Cap

49.0M

Sector

N/A

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.36

Market Cap

44.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
ESLA
Founded
2004
2021
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.0M
44.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LICN
ESLA
Price
$3.12
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
8.8K
345.7K
Earning Date
04-30-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,641,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$0.73
52 Week High
$19.00
$3.15

Technical Indicators

Market Signals
Indicator
LICN
ESLA
Relative Strength Index (RSI) 47.56 51.30
Support Level $2.83 $1.02
Resistance Level $3.12 $1.21
Average True Range (ATR) 0.17 0.14
MACD 0.00 0.04
Stochastic Oscillator 55.07 54.98

Price Performance

Historical Comparison
LICN
ESLA

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: